Efficacy of herbal medicines and standard antidepressants on neurotransmitter and behavioral outcomes in animal models of depression
DOI:
https://doi.org/10.3329/bjp.v20i2.81017Keywords:
Anthocyanin, Curcumin, Depression, Herbal, Meta-analysisAbstract
Herbal-based therapies show potential as antidepressants, though compara-tive efficacy remains uncertain. This study employed a meta-analysis to evaluate the efficacy of herbal interventions against standard antidepressants in animal depression models. A systematic search of PubMed, ScienceDirect, Cochrane, and Google Scholar (up to January 2025) identified 20 eligible studies. The behavior (open field test, tail suspension test) and neurotrans-mitters (serotonin, dopamine, noradrenaline) were analyzed as outcomes. Random-effects models were used, and risk of bias was assessed via SYRCLE. Curcumin improved open field test scores and increased serotonin and noradrenaline levels. Rosemary essential oil showed the strongest effect in the tail suspension test. Anthocyanins enhanced dopamine levels while zinc oxide nanoparticles exhibited effects comparable to curcumin. This finding supports the antidepressant potential of specific herbal, particularly curcumin, rosemary essential oil, and anthocyanins. Further standard research is necessary to confirm clinical relevance.
Downloads
102
62 Supplementary Table
14
References
Abdel-Azeem AS, Hegazy AM, Zeidan HM, Ibrahim KS, El-Sayed EM. Potential renoprotective effects of rosemary and thyme against gentamicin toxicity in rats. J Diet Suppl. 2017; 14: 380-94.
Almaghrabi SA, Clark SR, Baumert M. Bio-acoustic features of depression: A review. Biomed Signal Process Control. 2023; 85: 105020.
Amoateng P, Kukuia KKE, Mensah JA, Osei-Safo D, Adjei S, Eklemet AA, Vinyo, EA, Karikari TK. An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms. Metab Brain Dis. 2018; 33: 1359-68.
Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: Behavioural, biochemical, neurochemical and molecular evidence. Psychoneuroendocrinology 2011; 36: 1570-81.
Bhatt S, Behl T, Sehgal A, Singh S, Sharma N, Chigurupati S, Ahmed AS, Gari SBV. Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine. Environ Sci Pollut Res. 2022; 29: 27172-81.
Chang XR, Wang L, Li J, Wu DS. Analysis of anti-depressant potential of curcumin against depression induced male albino Wistar rats. Brain Res. 2016; 1642: 219-25.
Chen Y, Wang R, Li X, Wang Z, Cao B, Du J, Deng T, Han J, Yang M. Progress of research on the treatment of depression by traditional Chinese medicine prescriptions. Heliyon 2024; 10: e34970.
Chi X, Xue X, Pan J, Wu J, Shi H, Wang Y, Lu Y, Zhang Z, Ma K. Mechanism of lily bulb and Rehmannia decoction in the treatment of lipopolysaccharide-induced depression-like rats based on metabolomics study and network pharmacology. Pharm Biol. 2022; 60: 1850-64.
Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, Wang Y, Tang Y, Xia M, Li B. Major depressive disorder: Hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024; 9: 30.
Dahchour A. Anxiolytic and antidepressive potentials of rosmarinic acid: A review with a focus on antioxidant and anti-inflammatory effects. Pharmacol Res. 2022; 184: 106421.
Dudau LE, Moisa E, Sevastre-Berghian A, Moldovan R, Decea R, Donosa M, Filip GA, Stancu B. The effect of curcumin on reserpine-induced depression-like behaviour in rats. Psychiatry Res Neuroimaging. 2023; 334: 111682.
Fahmy HM, Aboalasaad FA, Mohamed AS, Elhusseiny FA, Khadrawy YA, Elmekawy A. Evaluation of the therapeutic effect of curcumin-conjugated zinc oxide nanoparticles on reserpine-induced depression in Wistar rats. Biol Trace Elem Res. 2024; 202: 2630-44.
Gazal M, Valente MR, Acosta BA, Kaufmann FN, Braganhol E, Lencina CL, Stefanello FM, Ghisleni G, Kaster MP. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats. Eur J Pharmacol. 2014; 724: 132-39.
Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: Advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci. 2022; 23: 1-28.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in knowledge bases. BMJ. 2003; 327: 557-60.
Hooijmans CR, Rovers MM, Vries RB, de Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014; 14: 1-9.
Hosseinzadeh S, Roshan VD, Mahjoub S. Continuous exercise training and curcumin attenuate changes in brain-derived neurotrophic factor and oxidative stress induced by lead acetate in the hippocampus of male rats. Pharm Biol. 2012; 51: 240-45.
Kolasa M, Faron-Gorecka A. Preclinical models of treatment-resistant depression: Challenges and perspectives. Pharmacol Rep. 2023; 75: 1326-40.
Kupferberg A, Hasler G. The social cost of depression: Investigating the impact of impaired social emotion regulation, social cognition, and interpersonal behavior on social functioning. J Affect Disord Rep. 2023; 14: 100631.
Kurnianingsih N, Hakim AR, Salsabila D, Fahanani AF, Harbiyanti NT, Ratnawati R. Anthocyanin extract from purple sweet potato improving neurotransmitter and locomotor in chronic stressed-mice. Iran J Vet Med. 2024; 18: 333-44.
Kurnianingsih N, Ratnawati R, Nazwar T, Ali M, Fatchiyah F. Purple sweet potatoes from east java of Indonesia revealed the macronutrient, anthocyanin compound and antidepressant activity candidate. Med Arch. 2021; 75: 94-100.
Lopresti AL. Potential role of curcumin for the treatment of major depressive disorder. CNS Drugs. 2022; 36: 123-41.
Madiha S, Haider S. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: Assessment by social interaction test and sucrose preference test. Metab Brain Dis. 2019; 34: 297-308.
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021; 12: 55-61.
Moorkoth S, Prathyusha NS, Manandhar S, Xue Y, Sankhe R, Pai KSR, Kumar N. Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: In silico and in vivo studies. Pharmacol Rep. 2021; 73: 1273-86.
Niu Y, Xu L, Qiao M, Wang Y. The anti-depression effect and mechanism of harmonious rosemary essential oil and its application in microcapsules. Mater Today Bio. 2025; 31: 101546.
Pan X, Chen L, Xu W, Bao S, Wang J, Cui X, Gao S, Liu K, Avasthi S, Zhang M, Chen R. Activation of monoaminergic system contributes to the antidepressant- and anxiolytic-like effects of J147. Behav Brain Res. 2021; 411: 113477.
Pojala K, Sayeli V. An experimental study evaluating antidepressant activity of methanolic leaf and fruit pulp extracts of Aegle marmelos in Wistar rats. Nat J Physiol Pharm Pharmacol. 2023; 13: 1456-60.
Ramaholimihaso T, Bouazzaoui F, Kaladjian A. Curcumin in depression: Potential mechanisms of action and current evidence- a narrative review. Front Psychiatry. 2020; 11: 572533.
Rothenberg DO, Zhang L. Mechanisms underlying the antidepressive effects of regular tea consumption. Nutrients 2019; 11: 1-38.
Sartim AG, Marques J, Silveira KM, Gobira PH, Guimarães FS, Wegener G, Joca SR. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology 2021; 195: 108679.
Sasaki K, Ferdousi F, Fukumitsu S, Kuwata H, Isoda H. Anti-depressant- and anxiolytic-like activities of Rosmarinus officinalis extract in rodent models: Involvement of oxytocinergic system. Biomed Pharmacother. 2021; 144: 112291.
Sasaki K, Linh TN, Hirano A, Tominaga K, Nukaga S, Nozaki H, Arimura T, Isoda H. Microalgae extract induces anti-depressant-like activity via neuroinflammation regulation and enhances the neurotransmitter system. Food Chem Toxicol. 2022; 170: 113508.
Sharma A, Singh T, Pathak D, Virmani T, Kumar G, Alhalmi A. Antidepressive-like effect of Aegle marmelos leaf extract in chronic unpredictable mild stress-induced depression-like behaviour in rats. Biomed Res Int. 2022; 2022.
Ueno H. Takahashi Y, Murakami S, Wani K, Matsumoto Y, Okamoto M, Ishihara T. Effect of simultaneous testing of two mice in the tail suspension test and forced swim test. Sci Rep. 2022; 12: 1-14.
World Health Organization (WHO). Depressive disorder (depression). World Health Organization Key Facts. USA. World Health Organization [accessed 2025 March 10]. https://www.who.int/news-room/fact-sheets/detail/depression.
Yan G, Zhang Y, Wang S, Yan Y, Liu M, Tian M, Tian W. Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study. Psychiatry Res. 2024; 337: 115958.
Zaa CA, Marcelo AJ, An Z, Medina-Franco JL, Velasco-Velázquez MA. Anthocyanins: Molecular aspects on their neuroprotective activity. Biomolecules 2023; 13: 1-16.
Zhai SY, Gu HW, Wang C, Li YS, Tang H. Gynura procumbens and selected metabolites: Amelioration of depressive-like behaviors in mice and risperidone-induced hyperprolactinemia in rats. Biomed Pharmacother. 2024; 173: 116361.
Zhang Y, Li L, Zhang J. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges. Basic Clin Pharmacol Toxicol. 2020; 127: 243-53.
Zhao X, Wang C, Zhang JF, Liu L, Liu AM, Ma Q, Zhou WH, Xu Y. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: Involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology 2014; 231: 2171-87.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nia Kurnianingsih, Imke Maria Del Rosario Puling, Wike Astrid Cahayani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
